ISSN : 2146-3123
E-ISSN : 2146-3131

Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory Confirmed Influenza in 2014-2015 season in Turkey: A Test-Negative Case Control Study
Can Hüseyin Hekimoğlu1, Mestan Emek2, Emine Avcı3, Selmur Topal3, Mustafa Demiröz4, Gül Ergör5
1Department of Microbiology Reference Laboratories, Public Health Institute of Turkey, Ankara, Turkey
2Antalya Public Health Directorate, Antalya, Turkey
3Department of Infectious Diseases, Public Health Institute of Turkey, Ankara, Turkey
4Bursa Public Health Directorate, Bursa, Turkey
5Department of Public Health, Dokuz Eylül University School of Medicine, İzmir, Turkey
DOI : 10.4274/balkanmedj.2017.0487

Summary

Background: Influenza has an important public health impact worldwide with its considerable annual morbidity among persons with or without risk factors and with its serious complications among persons in high-risk groups. Seasonal influenza vaccine is essential for preventing the burden of influenza in a population. Since the vaccine is reformulated each season according to the virus serotypes in circulation, its effectiveness can vary from season to season. Vaccine effectiveness is defined as relative risk reduction in vaccinated individuals in observational studies.
Aims: We aimed to calculate influenza vaccine effectiveness in preventing laboratory-confirmed influenza in the Turkish population for the first time using the national sentinel surveillance data in the 2014/15 influenza season.
Study Design: Test-negative case-control study.
Methods: We compared vaccination odds of influenza positive cases to influenza negative controls in the national influenza surveillance in Turkey to estimate influenza vaccine effectiveness.
Results: The IVE against influenza A (H1N1) (68.4% 95% CI: - 2.9 to 90.3), and B (44.6%, 95% CI: - 27.9 to 66.6) were moderate and the IVE against influenza A (H3N2) (75.0%, 95% CI: -86.1 to 96.7) was relatively high; all had low precision given the low vaccination coverage. Overall, influenza vaccination coverage rate was 4.2% (95% CI: 3.5 to 5.0), not sufficient to control the burden of influenza.
Conclusion: In Turkey, the national surveillance for influenza should be strengthened and be utilized annually for assessment of IVE with more precision. Annual influenza vaccine effectiveness in Turkey should continue to be monitored as part of the national sentinel influenza surveillance.
Keywords : Influenza, vaccine effectiveness, surveillance